InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,140.00
(
-0.18%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.47
(
0.34%
)
Bitcoin
60,875.47
(
-1.51%
)
Post# of 203990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

hayloft999

Send PM Follow Ignore
Followers 0
Posts 519
Boards Moderated 0
Alias Born 06/01/2006

hayloft999

Re: TallRob0 post# 27545

Tuesday, 07/18/2006 10:08:38 AM

Tuesday, July 18, 2006 10:08:38 AM

Post# of 203990
It is worthless until they are gaining revenues from it. Orhan drug status doesn't give a company revenue, sales does though.

I'm not saying that down the road this company doesn't have potential what I am saying though is that XKEM could have 100 best drugs in the world but if revenues are based on 100,000 sufferers from one drug the PPS will reflect that and until sales increase $0.12 looks a good price.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up